Acton Pharmaceuticals, Inc. — Form D
Acton Pharmaceuticals, Inc. of MARLBOROUGH, MA, a company, filed a Form D exempt-offering notice with the SEC on 2010-09-30. The offering totals $14.2M, of which $14.2M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2010-09-30
- Form: D
- Accession: 0001140361-10-039046
- Industry: Pharmaceuticals
- Exemptions: 06
- Total offering: $14.2M
- Amount sold: $14.2M
- Minimum investment: $591K
- Investors: 2
- Date of first sale: 2010-09-29
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-148359
Issuer
- Name: Acton Pharmaceuticals, Inc.
- CIK: 0001478610
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2008
- Address: 225 CEDAR HILL STREET, MARLBOROUGH, MA, 01752
- Phone: 508-624-8733
Officers, directors & promoters (8)
| Name | Role | Location |
|---|
| Scott Carter | Director | Bethesda, MD |
| John Simon | Director | Cambridge, MA |
| John Simon | Executive Officer | Cambridge, MA |
| John Simon | Promoter | Cambridge, MA |
| Daniel Kreisler | Director | Marlborough, MA |
| Daniel Kreisler | Executive Officer | Marlborough, MA |
| Daniel Kreisler | Promoter | Marlborough, MA |
| Thomas Phair | Executive Officer | Marlborough, MA |
Other filings by this issuer (2)
More